デフォルト表紙
市場調査レポート
商品コード
995635

オリゴヌクレオチド合成の世界市場 - 装置/サービス別 (合成装置/シンセサイザー、試薬、サービス)・技術別・核酸別・用途別・エンドユーザー別・地域別:市場規模・シェア・将来展望・機会分析

Oligonucleotide Synthesis Market, by Equipment & Services (Equipment/Synthesizer, Reagents, and Services ), by Technology, by Nucleic Acid, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 198 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.75円
オリゴヌクレオチド合成の世界市場 - 装置/サービス別 (合成装置/シンセサイザー、試薬、サービス)・技術別・核酸別・用途別・エンドユーザー別・地域別:市場規模・シェア・将来展望・機会分析
出版日: 2021年03月01日
発行: Coherent Market Insights
ページ情報: 英文 198 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

オリゴヌクレオチドは一般的に、ポリメラーゼ連鎖反応 (PCR) やPCRアッセイ、生物学的に関連する遺伝子パネルなどのプライマーとして使用されます。例えば、アンチセンスオリゴヌクレオチドは、mRNAの処理や翻訳を阻害することによってタンパク質合成のレベルを低下させるために使用されます。オリゴヌクレオチドはその他にも、DNA配列決定やDNAマイクロアレイ、蛍光in situハイブリダイゼーション(FISH)、核酸アプタマーといった用途で活用されています。多くの製薬企業が、オリゴヌクレオチドの需要増大を受けて、核酸ベースの治療法の開発に注力し、製造施設の拡張などを進めており、それが今後の市場の大きな促進材料になると期待されています。

当レポートでは、世界のオリゴヌクレオチド合成の市場について分析し、製品の概要や、市場の基本構造および促進・抑制要因、全体的な市場規模の見通し (金額ベース、2016年~2027年)、装置/サービス別・技術別・核酸の種類別・用途別・エンドユーザー別・地域別の詳細動向、主要企業のプロファイル・業績・戦略計画などを調査しております。

目次

第1章 分析目的・前提条件

第2章 市場概略

  • 分析概要
    • 市場の定義と範囲
  • エグゼクティブサマリー
  • COM (Coherent Opportunity Map:市場機会マップ)

第3章 市場の力学・規制・動向の分析

  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
  • 影響度の分析
  • 近年の主な動き
  • PEST分析

第4章 世界のオリゴヌクレオチド合成市場:新型コロナウイルス感染症 (COVID-19) 感染拡大の影響

  • 影響度の評価
  • COVID-19と戦うための各国政府の対応策

第5章 世界のオリゴヌクレオチド合成市場:装置・サービス別

  • イントロダクション
  • 合成装置/シンセサイザー
  • 試薬
  • サービス

第6章 世界のオリゴヌクレオチド合成市場:技術別

  • イントロダクション
  • カラムベース
  • マイクロアレイベース

第7章 世界のオリゴヌクレオチド合成市場:核酸の種類別

  • イントロダクション
  • DNA
  • RNA

第8章 世界のオリゴヌクレオチド合成市場:用途別

  • イントロダクション
  • 創薬
  • 治療

第9章 世界のオリゴヌクレオチド合成市場:エンドユーザー別

  • イントロダクション
  • 教育研究機関
  • 診断検査室
  • 製薬・バイオテクノロジー企業

第10章 世界のオリゴヌクレオチド合成市場:地域別

  • イントロダクション
  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋
  • 中東
  • アフリカ

第11章 競合情勢

  • ヒートマップ分析
  • 市場シェア分析
    • Thermo Fisher Scientific
    • Sigma-Aldrich Corporation
    • GE Healthcare
    • Integrated DNA Technologies, Inc.
    • TriLink BioTechnologies, Inc
    • BioAutomation Corporation
    • Twist Bioscience
    • Shanghai SynTheAll Pharmaceutical Co., Ltd.
    • CUSABIO Technology LLC
    • Synbio Technologies
    • GENEWIZ
    • Eurofins Scientific
    • Agilent Technologies
    • Kaneka Eurogentec SA
    • LGC, Biosearch Technologies
  • アナリストの見解

第12章 付録

目次

Title:
Oligonucleotide Synthesis Market, by Equipment & Services (Equipment/Synthesizer, Reagents, and Services (Oligo Synthesis, Modification, and Purification)), by Technology (Column-based, and Microarray-based), by Nucleic Acid (DNA and RNA), by Application (Drug Discovery and Therapeutics), by End User (Academic Research Institutes, Diagnostic Laboratories, and Pharmaceutical-Biotechnology Companies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Oligonucleotides are commonly used as primers for polymerase chain reaction (PCR), PCR assays, and panels for biologically related genes. Antisense oligonucleotides are used to reduce levels of protein synthesis by inhibiting mRNA processing or translation. Other uses of oligonucleotides include DNA sequencing, DNA microarrays, fluorescence in situ hybridization (FISH), and nucleic acid aptamers. Moreover, many pharmaceutical companies are focusing on developing nucleic acid-based therapeutics due to which the demand of oligonucleotide is increasing. Hence, market players are focusing on expanding their manufacturing facilities, which is expected to boost the market growth over the forecast period. For instance, in August 2020, Agilent Technologies Inc., announced the expansion of its state-of-the-art production facility in Frederick, Colorado, which develops manufactures oligos that hold potential to be used as treatments for diseases such as COVID-19, cardiovascular disease, cancer, rare and infectious diseases, and other conditions.

Market Dynamics:

Key players are focusing on various inorganic growth strategies such as collaborations, partnerships and agreements, which is expected to propel the growth of the global oligonucleotide synthesis market during the forecast period. For instance, on August 05, 2020, Evotec SE, a drug discovery and development company entered into a strategic partnership with Secarna Pharmaceuticals GmbH & Co. KG, a drug discovery company, for the development of antisense oligonucleotide therapies.

Moreover, in November 2019, CSBio, a peptide and instrumentation manufacturing company entered into a collaboration with Sunresin, a supplier of ion exchange resin and absorption & separation resin for the development of an optimized polystyrene resin for commercial scale oligonucleotide synthesis.

Key features of the study:

  • This report provides in-depth analysis of the global oligonucleotide synthesis market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global oligonucleotide synthesis market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans.
  • Key companies covered as a part of this study include Thermo Fisher Scientific, Sigma-Aldrich Corporation, GE Healthcare, Integrated DNA Technologies, Inc., TriLink BioTechnologies, Inc, BioAutomation Corporation, Twist Bioscience, Shanghai SynTheAll Pharmaceutical Co., CUSABIO Technology LLC, Synbio Technologies, GENEWIZ, Eurofins Scientific, Agilent Technologies, Kaneka Eurogentec S.A., and LGC, Biosearch Technologies
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, market expansion, and marketing tactics
  • The global oligonucleotide synthesis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oligonucleotide synthesis market.

Detailed Segmentation:

  • Global Oligonucleotide Synthesis Market, By Equipment & Services:
  • Equipment/Synthesizer
  • Reagents
  • Services
    • Oligo Synthesis
    • Modification
    • Purification
  • Global Oligonucleotide Synthesis Market, By Technology:
  • Column-based
  • Microarray-based
  • Global Oligonucleotide Synthesis Market, By Nucleic Acid Type:
  • DNA
  • RNA
  • Global Oligonucleotide Synthesis Market, By Application:
  • Drug Discovery
  • Therapeutics
  • Global Oligonucleotide Synthesis Market, By End User:
  • Academic Research Institutes
  • Diagnostic Laboratories
  • Pharmaceutical-Biotechnology Companies
  • Global Oligonucleotide Synthesis Market, By Region:
  • North America
    • By Equipment & Services
    • Equipment/Synthesizer
    • Reagents
    • Services
    • Oligo Synthesis
    • Modification
    • Purification
    • By Technology
    • Column-based
    • Microarray-based
    • By Nucleic Acid Type
    • DNA
    • RNA
    • By Application
    • Drug Discovery
    • Therapeutics
    • By End User
    • Academic Research Institutes
    • Diagnostic Laboratories
    • Pharmaceutical-Biotechnology Companies
    • By Country:
    • U.S.
    • Canada
  • Latin America
    • By Equipment & Services
    • Equipment/Synthesizer
    • Reagents
    • Services
    • Oligo Synthesis
    • Modification
    • Purification
    • By Technology
    • Column-based
    • Microarray-based
    • By Nucleic Acid Type
    • DNA
    • RNA
    • By Application
    • Drug Discovery
    • Therapeutics
    • By End User
    • Academic Research Institutes
    • Diagnostic Laboratories
    • Pharmaceutical-Biotechnology Companies
    • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Equipment & Services
    • Equipment/Synthesizer
    • Reagents
    • Services
    • Oligo Synthesis
    • Modification
    • Purification
    • By Technology
    • Column-based
    • Microarray-based
    • By Nucleic Acid Type
    • DNA
    • RNA
    • By Application
    • Drug Discovery
    • Therapeutics
    • By End User
    • Academic Research Institutes
    • Diagnostic Laboratories
    • Pharmaceutical-Biotechnology Companies
    • By Country:
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Equipment & Services
    • Equipment/Synthesizer
    • Reagents
    • Services
    • Oligo Synthesis
    • Modification
    • Purification
    • By Technology
    • Column-based
    • Microarray-based
    • By Nucleic Acid Type
    • DNA
    • RNA
    • By Application
    • Drug Discovery
    • Therapeutics
    • By End User
    • Academic Research Institutes
    • Diagnostic Laboratories
    • Pharmaceutical-Biotechnology Companies
    • By Country:
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Equipment & Services
    • Equipment/Synthesizer
    • Reagents
    • Services
    • Oligo Synthesis
    • Modification
    • Purification
    • By Technology
    • Column-based
    • Microarray-based
    • By Nucleic Acid Type
    • DNA
    • RNA
    • By Application
    • Drug Discovery
    • Therapeutics
    • By End User
    • Academic Research Institutes
    • Diagnostic Laboratories
    • Pharmaceutical-Biotechnology Companies
    • By Country:
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • By Equipment & Services
    • Equipment/Synthesizer
    • Reagents
    • Services
    • Oligo Synthesis
    • Modification
    • Purification
    • By Technology
    • Column-based
    • Microarray-based
    • By Nucleic Acid Type
    • DNA
    • RNA
    • By Application
    • Drug Discovery
    • Therapeutics
    • By End User
    • Academic Research Institutes
    • Diagnostic Laboratories
    • Pharmaceutical-Biotechnology Companies
    • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Thermo Fisher Scientific
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sigma-Aldrich Corporation
    • GE Healthcare
    • Integrated DNA Technologies, Inc.
    • TriLink BioTechnologies, Inc
    • BioAutomation Corporation
    • Twist Bioscience
    • Shanghai SynTheAll Pharmaceutical Co.
    • CUSABIO Technology LLC
    • Synbio Technologies
    • GENEWIZ
    • Eurofins Scientific
    • Agilent Technologies
    • Kaneka Eurogentec S.A.
    • LGC, Biosearch Technologies

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Equipment & Services
    • Market Snippet, By Technology
    • Market Snippet, By Nucleic Acid Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Developments
  • PEST Analysis

4. Global Oligonucleotide Synthesis Market - Impact of Coronavirus (COVID-19) Pandemic

  • Impact assessment
  • Government measures to combat COVID-19

5. Global Oligonucleotide Synthesis Market, By Equipment & Services, 2016 - 2027, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Equipment/Synthesizer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Bn)
  • Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Bn)
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Bn)
    • Oligo Synthesis
    • Modification
    • Purification

6. Global Oligonucleotide Synthesis Market, By Technology, 2016 - 2027, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • ColuBn-based
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Bn)
  • Microarray-based
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Bn)

7. Global Oligonucleotide Synthesis Market, By Nucleic Acid Type, 2016 - 2027, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • DNA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Bn)
  • RNA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Bn)

8. Global Oligonucleotide Synthesis Market, By Application, 2016 - 2027, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Drug Discovery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Bn)
  • Therapeutics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Bn)

9. Global Oligonucleotide Synthesis Market, By End User, 2016 - 2027, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Academic Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Bn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Bn)
  • Pharmaceutical-Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Bn)

10. Global Oligonucleotide Synthesis Market, By Region, 2016 - 2027, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2027
  • North America
    • Market Size and Forecast, By Equipment & Services, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By Technology, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By Nucleic Acid Type, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Bn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Equipment & Services, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By Technology, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By Nucleic Acid Type, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Equipment & Services, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By Technology, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By Nucleic Acid Type, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Bn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Equipment & Services, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By Technology, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By Nucleic Acid Type, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Equipment & Services, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By Technology, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By Nucleic Acid Type, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Equipment & Services, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By Technology, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By Nucleic Acid Type, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Bn)
    • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Bn)
    • South Africa
    • Central Africa
    • North Africa

11. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Thermo Fisher Scientific
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sigma-Aldrich Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • GE Healthcare
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Integrated DNA Technologies, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • TriLink BioTechnologies, Inc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • BioAutomation Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Twist Bioscience
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Shanghai SynTheAll Pharmaceutical Co., Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • CUSABIO Technology LLC
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Synbio Technologies
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • GENEWIZ
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Eurofins Scientific
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Agilent Technologies
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Kaneka Eurogentec S.A.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • LGC, Biosearch Technologies
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

12. Section

  • References
  • Research Methodology
  • About us and Sales Contact